Stockscreener 앱 받기
1.60
0.95%
0.015
Biomerica Inc 주식(BMRA)의 최신 뉴스
BMRA Q2 2026 Earnings: EPS Loss of $0.44 Highlights Cost-Heavy Development PhaseEarnings Season Review - Vinanet
Biomerica (BMRA) Slips 2.47% to $1.58 as Shares Test Key Support ZonePassive Flow - dars.gov.et
Biomerica (BMRA) Advances 3.18% to $1.62, Pressing Against Key Resistance at $1.70Volume Rate Change - Vinanet
Biomerica Inc (BMRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biomerica (BMRA) Edges Lower to $1.5: Navigating Support and ResistanceStock Picks - Vinanet
BMRA Q2 2026 Earnings: Loss of $0.44 Per Share Amid Thin DisclosureBook Value Growth - Vinanet
Biomerica Inc (BMRA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biomerica (BMRA) Q2 2026 Earnings: Net Loss Per Share of -$0.44 Highlights Challenging QuarterNet Profit Margin - dars.gov.et
BMRA|Biomerica Inc|Price:1.620|Chg%:+0.035 - TradingKey
Biomerica Inc (BMRA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Biomerica Inc (BMRA) Income Statement - tradingkey.com
Biomerica Inc (BMRA) Institutional Confidence - TradingKey
Biomerica Inc (BMRA) Valuation: PE, PB & Fair Value Analysis - TradingKey
BMRA|Biomerica Inc|Price:1.540|Chg%:-0.080 - TradingKey
Biomerica Inc (BMRA) Balance Sheet - TradingKey
Biomerica (BMRA) Holds Near Support After Minor DeclineDealer Gamma - Vinanet
BMRA|Biomerica Inc|Price:1.585|Chg%:+0.015 - TradingKey
Biomerica, Inc. Revenue Breakdown – NASDAQ:BMRA - TradingView
Biomerica Inc. (BMRA) Edges Higher in Quiet TradingHedge Fund Favorites - dars.gov.et
Biomerica Inc. (BMRA) Edges Higher in Low-Volume Trading, Testing Key Resistance ZoneMAMA Signal - dars.gov.et
BMRA Q2 2026 Earnings: EPS Misses as Revenue Data Unavailable, Stock Rebounds SlightlyEarnings Deceleration Risk - Vinanet
BMRA Q2 2026 Earnings: Reported Loss of -$0.44 per Share; Stock Gains $1.52Analyst Consensus Shift - Vinanet
BMRA Q2 2026 Earnings: Net Loss of $0.44 per Share; Stock Declines 3.55%Analyst Consensus Shift - Vinanet
BMRABiomerica Inc Short Interest - Finviz
Biomerica Inc. (BMRA) Q2 2026 Earnings: Negative EPS as Company Continues Operational FocusQuarterly Earnings Report - dars.gov.et
BMRA Q2 2026 Earnings: Diagnostics Firm Posts Wider-Than-Expected Loss as Stock RisesProfitability Analysis - dars.gov.et
Price to sales forward of Biomerica, Inc. – NASDAQ:BMRA - TradingView
Enterprise value to EBITDA forward of Biomerica, Inc. – NASDAQ:BMRA - TradingView
Price to earnings forward of Biomerica, Inc. – NASDAQ:BMRA - TradingView
Biomerica Inc. (BMRA) Edges Higher as Stock Tests Key Resistance LevelWyckoff Accumulation - dars.gov.et
Biomerica Inc (BMRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Biomerica Inc (BMRA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Biomerica | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
BMRA Q1 2026 Earnings: Net Loss Reported Amid Operational ChallengesFree Cash Flow Trends - dars.gov.et
Biomerica Inc (BMRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biomerica Inc (BMRA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biomerica (BMRA) Slips Slightly to $2.05; Near Key Support Amid Quiet TradingDark Pool Volume - newsline.com
Biomerica (BMRA) Edges Lower, Testing Key Support at $1.95ETF Liquidity - newsline.com
Biomerica (BMRA) Edges Higher as Stock Holds Above Key Support LevelIV Contraction - newsline.com
BMRA Q1 2026 Earnings: Net Loss of $0.44 per Share; Stock Declines 0.92%Analyst Consensus Shift - newsline.com
Biomerica (BMRA) Slides Slightly as Stock Approaches Key Support LevelIceberg Order - newsline.com
Biomerica (BMRA) Q1 2026 Earnings: Narrowing Loss Amid Ongoing Operational ChallengesReturn On Capital - newsline.com
Biomerica, Inc. Announces $500,000 Securities Purchase Agreement and Secured Promissory Note – Form 8-K Filing, May 29, 2026 – Minichart - Minichart
Biomerica Enters Related-Party Deal to Boost Liquidity - TipRanks
Biomerica to Sell 6% Diagnosis Stake for $500,000; Issues 8% Note Pending Transfer - TradingView
Biomerica (BMRA) sells 6% Diagnosis S.A. stake to CEO-affiliated buyers - Stock Titan
Biomerica Inc. (BMRA) Sees Modest Gain as Shares Test Key ResistanceDip Buy Trade - newsline.com
BMRA Q1 2026 Earnings: Operating Loss Widens to $0.44 per Share as Pre-Revenue Biotech Advances Pipeline - newsline.com
Biomerica secures USD 1.75M contract for IVD diagnostic development - Medical Buyer
BMRA Stock Price, Quote & Chart | BIOMERICA INC (NASDAQ:BMRA) - ChartMill
Biomerica Inc. Awarded $1.75 Million Contract for IVD Product Development - geneonline.com
Biomerica (BMRA) Secures Master Services Agreement for Diagnosti - GuruFocus
Biomerica Inc. (BMRA) Holds Near Support Amid Modest PullbackBeta Neutral Pair - The Legal Advocate
Biomerica Wins $1.75M Contract to Develop Diagnostic Tests - Orange County Business Journal
1.33%
0.04%
자본화:
|
볼륨(24시간):